Santa Barbara breast implant developer Sientra released preliminary financial results for its fourth quarter, saying sales had risen 72 percent year-over-year to $19 million. The unaudited results show a nearly 200 percent gain in the company’s miraDry segment, which rose from $2.9 million during the fourth quarter of 2017 to $8.6 million in the most…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
